Incidence trends of surgical complications after oesophagectomy for oesophageal cancer: a population-based, nationwide cohort study in Finland over 30 years
Ville E.J. Sirviö, Jari V. Räsänen, Olli Helminen, Mika Helmiö, Heikki Huhta, Raija Kallio, Vesa Koivukangas, Arto Kokkola, Simo Laine, Elina Lietzen, Sanna Meriläinen, Vesa-Matti Pohjanen, Tuomo Rantanen, Ari Ristimäki, Juha Saarnio, Eero Sihvo, Vesa Toikkanen, Tuula Tyrväinen

TL;DR
This study examines how surgical complications after oesophagectomy for oesophageal cancer have changed in Finland over 30 years.
Contribution
The study provides population-based, nationwide data on complication trends after oesophagectomy for oesophageal cancer.
Findings
Major complications and 90-day mortality decreased significantly over 30 years.
Pneumonia and anastomotic leak rates increased despite overall improvements.
Pulmonary and gastrointestinal complications were the most common categories.
Abstract
Knowledge on the incidence of surgical complications after oesophagectomy for oesophageal cancer in nationwide practice is scarce. The aim of this study was to assess complication trends after oesophagectomy in a nationwide, population-based, unselected cohort. All patients undergoing oesophagectomy for oesophageal cancer in Finland in 1987–2016 were included. All complications defined by the Esophagectomy Complications Consensus Group (ECCG) were reported in three 10-year periods. Chi-square test and Kruskal-Wallis test were used to compare outcomes in these periods. A total of 1493 patients were included. From 1987 to 1996 to 2007–2016, improvements were seen in the rate of major complications (49% vs. 43%, p = 0.039), length of hospital stay (19 vs. 14 days, median, p < 0.001), length of ICU-stay (3 vs. 2 days, median, p < 0.001) and 90-day mortality (17.9% vs. 5.4%, p < 0.001),…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEsophageal Cancer Research and Treatment · Esophageal and GI Pathology · Gastric Cancer Management and Outcomes
